XASX
CCO
Market cap1mUSD
Oct 09, Last price
0.00AUD
1D
0.00%
1Q
-66.67%
IPO
-99.01%
Name
Calmer Co International Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
105.57%
Rev. gr., 5y
47.56%
Revenues
8m
+1.01%
Net income
-4m
L-4.62%
CFO
-3m
L-32.81%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Fiji Kava Limited operates as a health and wellness enterprise specializing in medicinal kava products, conducting its business across Australia, New Zealand, Fiji, and the United States. The company manufactures and distributes various noble kava extract products, including capsules and powder mixes, marketed under its Fiji Kava and Taki Mai labels. Customers can also acquire their products through the official website, fijikava.com. Established in 2014, Fiji Kava Limited has its main office located in West End, Australia.
Key people
John Homewood
Non-Executive Chairman of the Board · since 2024
Brian Casutto
Managing Director - USA · since 2021
Zane Yoshida
Chief Executive Officer, Managing Director, Executive Director · since 2025
Matthew Kowal
Chief Commercial Officer · since 2025
Natalie Climo
Company Secretary · since 2024
Griffon Emose
Non-Executive Director · since 2023
Anthony Noble
Non-Executive Director · since 2025
James Tonkin
Non-Executive Director · since 2023
Independent Non-Executive Director · since 2020
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑06 | 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT |